InsiderDB
Sign inStart free trial

Rep. John James bought Cardinal Health (CAH)

Rep. John James (R-MI-10) · $1K–$15K · traded Jun 3, 2024

Transaction
Bought
Amount
$1K–$15K
Owner
Not stated
Traded
Jun 3, 2024
Disclosed
Sep 2, 2024
Days to disclose
91 (after the 45-day deadline)
Asset type
Stock
As filed
Cardinal Health, Inc. Common Stock
Industry
Medical - Distribution · Healthcare
Official filing ↗All of James's tradesAll Congress trades in CAH

Other trades in this filing

All of James's trades →

Recent Congress trades in CAH

Company context for CAH

Recent records for the company. These may have been published before or after this trade; compare the dates before drawing a connection.

  1. CAHLobbying report·Lobbying disclosures

    CAH: third_quarter 2026 lobbying report

    Education on supply chain issues, drug shortages, domestic manufacturing, medical device environmental issues; Issues related to the medical supply chain and transportation. Issues related to tariffs, trade, and U.S. trade policy. Issues related to Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS), competitive bidding, and reimbursement to home healthcare agencies. Issues related to drug pricing, bona fide service fees, pharmacies, provider status, biosimilars, cell and gene therapy, food is medicine, pharmacy services administrative organizations; Issues related to prov

    Public: Oct 20, 2026, 1:54 PM EDTOriginal source ↗
  2. CAHLobbying report·Lobbying disclosures

    CAH: third_quarter 2026 lobbying report

    General issues affecting the health care industry such as drug pricing, pharmaceutical drugs, medical devices, workforce shortages, and product shortages. Pharmaceutical tariffs Supply chain issues affecting the pharmaceutical industry

    Public: Oct 16, 2026, 3:29 PM EDTOriginal source ↗
  3. CAHLobbying report·Lobbying disclosures

    CAH: second_quarter 2026 lobbying report

    Issues related to drug pricing, bona fide service fees, pharmacies, provider status, biosimilars, cell and gene therapy, food is medicine, and pharmacy services administrative organizations; Issues related to provider reimbursement, Medicare and Medicaid, workforce shortages, and product shortages; Issues related to Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS), competitive bidding, reimbursement to home healthcare agencies, and acute hospital care at home services; H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act; H.R. 5031/S. 3159, Preservin

    Public: Jul 20, 2026, 10:07 AM EDTOriginal source ↗

From a periodic transaction report filed under the STOCK Act. Amounts are the ranges members report. Nothing here is investment advice.